Pharmaceutical preparation for treating male climacteric syndrome

A pharmaceutical preparation and syndrome technology, applied in the field of medicine, can solve problems such as unsatisfactory therapeutic effect and safety, aggravation, etc., and achieve the effect of convenient administration, good patient tolerance, and advanced dosage form

Inactive Publication Date: 2016-03-23
QINGDAO MERRITT MEDICAL TECH CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The current Western medicine treatment for male menopausal syndrome is oral testosterone drugs, but it must be noted that supplementing testosterone may aggravate latent prostate diseases, such as b

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1 capsule

[0027] The raw materials of the present invention are weighed in the following parts by weight: 14 parts of rehmannia glutinosa, 12 parts of dodder, 7 parts of dogwood, 10 parts of mother-of-pearl, 12 parts of schisandra, 10 parts of calcined keel, 5 parts of turmeric, and 5 parts of salvia.

[0028] The preparation process is as follows:

[0029] Take the above Chinese medicine components according to the aforementioned weight and crush them into coarse powder respectively, and wrap them with gauze; add water of 8 times the total weight of the medicinal materials for the first time, soak in warm for 4 hours, decoct for 2 hours, and filter while hot; Add 4 times the amount of water, decoct for 2 hours, and filter while hot; combine the two decoction filtrates; when the filtrate is concentrated to an extract with a relative density of 1.10 to 1.15 at 55°C, add a pharmaceutically acceptable carrier, and Technology makes capsule of the present inven...

Embodiment 2

[0031] Embodiment 2 oral liquid

[0032] The raw materials of the present invention are weighed in the following parts by weight: 14 parts of rehmannia glutinosa, 12 parts of dodder, 7 parts of dogwood, 10 parts of mother-of-pearl, 12 parts of schisandra, 10 parts of calcined keel, 5 parts of turmeric, and 5 parts of salvia.

[0033] The preparation process is as follows:

[0034] Take the above Chinese medicine components according to the aforementioned weight and crush them into coarse powder respectively, and wrap them with gauze; add water of 8 times the total weight of the medicinal materials for the first time, soak in warm for 4 hours, decoct for 2 hours, and filter while hot; Add 4 times the amount of water, decoct for 2 hours, and filter while hot; combine the two decoction filtrates; when the filtrate is concentrated to an extract with a relative density of 1.10 to 1.15 at 55°C, add a pharmaceutically acceptable carrier, and Technology makes the oral liquid of the p...

Embodiment 3

[0036] Embodiment 3 granules

[0037] The raw materials of the present invention are weighed in the following parts by weight: 14 parts of rehmannia glutinosa, 12 parts of dodder, 7 parts of dogwood, 10 parts of mother-of-pearl, 12 parts of schisandra, 10 parts of calcined keel, 5 parts of turmeric, and 5 parts of salvia.

[0038] The preparation process is as follows:

[0039] Take the above Chinese medicine components according to the aforementioned weight and crush them into coarse powder respectively, and wrap them with gauze; add water of 8 times the total weight of the medicinal materials for the first time, soak in warm for 4 hours, decoct for 2 hours, and filter while hot; Add 4 times the amount of water, decoct for 2 hours, and filter while hot; combine the two decoction filtrates; when the filtrate is concentrated to an extract with a relative density of 1.10 to 1.15 at 55°C, add a pharmaceutically acceptable carrier, and Process to prepare the granules of the prese...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a pharmaceutical preparation for treating the male climacteric syndrome and a preparation method thereof. The pharmaceutical preparation is prepared from prepared rehmannia roots, semen cuscutae, cornus officinalis, mothers of pearl, Chinese magnoliavine fruit, calcined keel, curcuma aromatica and salviae miltiorrhizae. The pharmaceutical preparation is reasonable in composition, rigorous in compatibility and easy to prepare, has remarkable treatment effects of nourishing livers and kidneys, nourishing qi to generate fluid and suppressing hyperactive liver and subsiding yang, is rapid in effect, treats both symptoms and root causes, and is an effective medicine for treating the male climacteric syndrome, especially the liver-kidney yin deficiency type male climacteric syndrome.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical preparation for treating male climacteric syndrome. Background technique [0002] Andropause syndrome refers to a series of symptoms caused by testicular atrophy, decreased secretion of testosterone, feedback stimulation of pituitary secretion, decreased response of atrophic testes to gonadotropins, and imbalance of sex hormone regulation in the body. The main clinical manifestations are hot flashes and night sweats, irritability, depression, anxiety and depression, palpitations and dreaminess, soreness of the waist and knees, loss of libido, white hair and hair loss, timidity, jealousy and suspicion and other symptoms of neurasthenia. The age of onset is generally about 55-65 years old, and the clinical manifestations vary in severity, the mild ones are even unaware, and the severe ones affect life and work, and the patients feel very painful. [0...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P15/12A61K35/618A61K35/02
CPCA61K36/804A61K9/0095A61K9/08A61K35/02A61K35/618A61K36/39A61K36/40A61K36/537A61K36/57A61K36/79A61K36/9066A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 吴兴连
Owner QINGDAO MERRITT MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap